H. Roder

发表

Accumulation of Pathological Tau Species and Memory Loss in a Conditional Model of Tauopathy

K. Ashe, M. Hutton, Z. Wszolek, 2007, The Journal of Neuroscience.

Brain protein kinase PK40erk converts TAU into a PHF-like form as found in Alzheimer's disease.

V. Ingram, H. Roder, P. Eden, 1993, Biochemical and biophysical research communications.

Inhibition of PHF-like tau hyperphosphorylation in SH-SY5Y cells and rat brain slices by K252a.

H. Klafki, H. Roder, Sandrine Ferrand, 2008, Journal of Alzheimer's disease : JAD.

Microtubule-associated protein tau as a therapeutic target in neurodegenerative disease

M. Hutton, H. Roder, 2007, Expert opinion on therapeutic targets.

Prospect of therapeutic approaches to tauopathies.

H. Roder, 2003 .

Prospect of therapeutic approaches to tauopathies

H. Roder, 2003, Journal of Molecular Neuroscience.

Phosphorylation-dependent Monoclonal Tau Antibodies Do Not Reliably Report Phosphorylation by Extracellular Signal-regulated Kinase 2 at Specific Sites*

H. Roder, J. Witowsky, G. Davis, 1997, The Journal of Biological Chemistry.

Highly Enantioselective Homoaldol Additions with Chiral N‐Allylureas—Application to the Synthesis of Optically Pure γ‐Lactones

K. Peters, H. Roder, E. Peters, 1984 .

Changes in Dendritic structure and function following Hippocampal Lesions: correlations with developmental events?

N. Spruston, D. Turner, H. Wheal, 1998, Progress in Neurobiology.

Better Utilization of Mouse Models of Neurodegenerative Diseases in Preclinical Studies: From the Bench to the Clinic.

H. Welzl, H. Roder, C. Janus, 2016, Methods in molecular biology.

Phosphatase Resistance of ERK2 Brain Kinase PK40erk2

H. Roder, F. Hoffman, Werner Schröder, 1995, Journal of neurochemistry.

Kinase inhibitors arrest neurodegeneration in cell and C. elegans models of LRRK2 toxicity.

Xiongwei Zhu, D. Alessi, Shu G. Chen, 2013, Human molecular genetics.

HIGHLY ENANTIOSELECTIVE HOMOALDOL ADDITION WITH CHIRAL N-ALLYLUREAS - USE FOR THE SYNTHESIS OF OPTICALLY PURE Γ-LACTONES

K. Peters, H. Roder, E. Peters, 1985 .

An inhibitor of tau hyperphosphorylation prevents severe motor impairments in tau transgenic mice.

N. Plesnila, D. Dickson, M. Hutton, 2006, Proceedings of the National Academy of Sciences of the United States of America.

Tau Transgenic Mouse Models in Therapeutic Development

H. Roder, 2009 .

Activation of neuronal extracellular receptor kinase (ERK) in Alzheimer disease links oxidative stress to abnormal phosphorylation.

N. Holbrook, M. Smith, A. Nunomura, 1999, Neuroreport.

Sex difference in pathology and memory decline in rTg4510 mouse model of tauopathy

C. Janus, M. Yue, H. Roder, 2011, Neurobiology of Aging.

Hyperphosphorylation of human TAU by brain kinase PK40erk beyond phosphorylation by cAMP-dependent PKA: relation to Alzheimer's disease.

V. Ingram, B. Blanchard, H. Roder, 1994, Biochemical and biophysical research communications.

Phosphorylation and dephosphorylation of distinct isoforms of the heavy neurofilament protein NF-H

D. Michaelson, H. Roder, L. Soussan, 1995, Cellular and Molecular Neurobiology.